| Dr Matthew Jared Fradkin, MD | |
|
2211 Queen Anne Ave N, Seattle, WA 98109-2367 | |
| (206) 861-8500 | |
| (206) 861-8501 |
| Full Name | Dr Matthew Jared Fradkin |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2211 Queen Anne Ave N, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013282581 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A135505 (California) | Secondary |
| 208000000X | Pediatrics | MD60663357 (Washington) | Primary |
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139724 PECOS PAC ID: 9537072814 Enrollment ID: O20031112000189 |
News Archive
Despite their widespread use by parents and caregivers, over-the-counter (OTC) cold and cough medicines have carried a warning by the FDA since 2008, and still have the potential to cause serious adverse events in infants and children. Conservative therapies, including nasal suctioning, humidification, and nasal saline, should be recommended over routine use of OTC cough/cold products in infants and children, according to a new commentary published in the May 2010 issue of Otolaryngology - Head and Neck Surgery.
GenoMed announced today that it received its second patent (US Patent #6,998,404) for the "Treatment or prevention of acute renal failure." Acute kidney failure usually happens when a patient gets dehydrated.
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has obtained a worldwide license from Hologic Inc. for that company's Invader, Invader plus and real-time Invader detection chemistries for the field of colorectal cancer screening.
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Jared Fradkin, MD Po Box 25608, Salt Lake City, UT 84125-0608 Ph: (206) 320-4476 | Dr Matthew Jared Fradkin, MD 2211 Queen Anne Ave N, Seattle, WA 98109-2367 Ph: (206) 861-8500 |
News Archive
Despite their widespread use by parents and caregivers, over-the-counter (OTC) cold and cough medicines have carried a warning by the FDA since 2008, and still have the potential to cause serious adverse events in infants and children. Conservative therapies, including nasal suctioning, humidification, and nasal saline, should be recommended over routine use of OTC cough/cold products in infants and children, according to a new commentary published in the May 2010 issue of Otolaryngology - Head and Neck Surgery.
GenoMed announced today that it received its second patent (US Patent #6,998,404) for the "Treatment or prevention of acute renal failure." Acute kidney failure usually happens when a patient gets dehydrated.
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has obtained a worldwide license from Hologic Inc. for that company's Invader, Invader plus and real-time Invader detection chemistries for the field of colorectal cancer screening.
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.
› Verified 7 days ago
Dr. James Toliver Bennett Jr., M.D., PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Genetic Medicine, Seattle, WA 98105 Phone: 206-987-2056 | |
Dr. Leslie Ann Dervan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Mb.10.620, Seattle, WA 98105 Phone: 206-987-0293 | |
Dr. Indi Trehan, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2000 | |
Alexa Mason, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne # Oc.7830, Seattle, WA 98105 Phone: 206-987-2525 | |
Dr. Gloria A. Arand, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3530 | |
Marcella Theresia Mascher Denen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195 Phone: 206-543-0065 | |
Elizabeth Amy Hicks, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2599 Fax: 206-987-2599 |